Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$596M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$429M |
| 3 |
Verizon
VZ
|
+$399M |
| 4 |
Amgen
AMGN
|
+$214M |
| 5 |
Citizens Financial Group
CFG
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$561M |
| 2 |
iShares National Muni Bond ETF
MUB
|
+$535M |
| 3 |
Oracle
ORCL
|
+$144M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$143M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.17% |
| 2 | Financials | 13.07% |
| 3 | Healthcare | 12.05% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Industrials | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
IDEAYA Biosciences
IDYA
$3.41B
| $1.38M | ﹤0.01% |
65,636
+21,814
| +50% | +$448K |
|
2827
Boston Omaha
BOC
$423M
| $1.37M | ﹤0.01% |
43,140
+8,975
| +26% | +$261K |
|
2828
CleanSpark
CLSK
$3.51B
| $1.36M | ﹤0.01% |
81,973
+73,141
| +828% | +$1.34M |
|
2829
Luxfer Holdings
LXFR
$456M
| $1.36M | ﹤0.01% |
60,905
+1,909
| +3% | +$41.5K |
|
2830
Tarsus Pharmaceuticals
TARS
$2.51B
| $1.35M | ﹤0.01% |
46,573
+4,950
| +12% | +$155K |
|
|
AFIB
2831
DELISTED
Acutus Medical Inc
AFIB
| $1.35M | ﹤0.01% |
79,267
-1,308
| -2% | -$19.1K |
|
|
FREE
2832
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
| $1.34M | ﹤0.01% |
92,721
+79,235
| +588% | +$1.06M |
|
2833
Harmony Biosciences
HRMY
$2.01B
| $1.34M | ﹤0.01% |
47,377
+33,610
| +244% | +$1.01M |
|
2834
TETRA Technologies
TTI
$1.11B
| $1.34M | ﹤0.01% |
308,188
+260,174
| +542% | +$857K |
|
2835
Finance of America Companies
FOA
$211M
| $1.34M | ﹤0.01% |
+17,500
| New | +$1.69M |
|
|
TIG
2836
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
| $1.33M | ﹤0.01% |
88,065
+10,629
| +14% | +$173K |
|
2837
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.4B
| $1.32M | ﹤0.01% |
42,305
-7,653
| -15% | -$240K |
|
2838
Hovnanian Enterprises
HOV
$727M
| $1.32M | ﹤0.01% |
+12,434
| New | +$1.45M |
|
2839
Loop Industries
LOOP
$35.3M
| $1.32M | ﹤0.01% |
106,948
+7,129
| +7% | +$69.5K |
|
|
SCU
2840
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $1.31M | ﹤0.01% |
53,375
+6,669
| +14% | +$160K |
|
2841
Mirum Pharmaceuticals
MIRM
$6.58B
| $1.3M | ﹤0.01% |
75,418
-899
| -1% | -$16.1K |
|
|
LBC
2842
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $1.3M | ﹤0.01% |
109,639
-7,117
| -6% | -$83.9K |
|
2843
Kartoon Studios
TOON
$35.5M
| $1.3M | ﹤0.01% |
70,460
+59,831
| +563% | +$1.05M |
|
|
VNTR
2844
DELISTED
Venator Materials PLC
VNTR
| $1.29M | ﹤0.01% |
272,305
+8,429
| +3% | +$40.4K |
|
2845
Vor Biopharma
VOR
$1.13B
| $1.29M | ﹤0.01% |
3,452
-210
| -6% | -$104K |
|
|
PSTX
2846
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $1.28M | ﹤0.01% |
128,065
-13,451
| -10% | -$120K |
|
|
ACBI
2847
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $1.27M | ﹤0.01% |
49,731
-1,589
| -3% | -$42K |
|
|
STR
2848
DELISTED
Sitio Royalties
STR
| $1.27M | ﹤0.01% |
62,300
-3,418
| -5% | -$65.6K |
|
2849
Veru
VERU
$34.8M
| $1.26M | ﹤0.01% |
15,643
+1,743
| +13% | +$154K |
|
|
BFX
2850
DELISTED
BowFlex Inc.
BFX
| $1.26M | ﹤0.01% |
74,605
-51,049
| -41% | -$860K |
|
Similar funds
Charles Schwab's Q2 2021 Portfolio in Review
As of Q2 2021, Charles Schwab held 3,648 positions worth $301B, up 10% from $273B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2021 filing shows 163 new, 2,481 increased, 676 reduced and 240 closed positions. Its largest new stake was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M. The largest sale was iShares MBS ETF, an estimated $561M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2021 buy was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M.
- Charles Schwab added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2021, an estimated $596M increase.
- Charles Schwab's biggest Q2 2021 reduction was iShares MBS ETF, cutting an estimated $561M.
- Charles Schwab fully exited Invesco S&P 500 Low Volatility ETF in Q2 2021, selling an estimated $92.7M.
- Charles Schwab's ten largest holdings make up 17% of its $301B portfolio in Q2 2021.
- Charles Schwab opened 163 new positions and closed 240 in Q2 2021.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $301B.
Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.